SCHEMBL14760427

SCHEMBL14760427

CCCCCOP(=O)(CC(=O)O)OCCCCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 8/20 0.53
LPAR2 Q9HBW0 6/20 0.53
LPAR1 Q92633 3/20 0.53
CYP3A4 P08684 1/20 0.45
AKR1B1 P15121 1/20 0.41
PPARG P37231 3/20 0.40
PPARD Q03181 3/20 0.40
PPARA Q07869 3/20 0.40
TSHR P16473 2/20 0.40
GPR84 Q9NQS5 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
TLR2 O60603 1/20 0.40
MEN1 O00255 1/20 0.40
ESR1 P03372 1/20 0.40
FABP4 P15090 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4267782 0.98 LPAR3 (0.57) LPAR3LPAR2LPAR1CYP3A4PPARG
SCHEMBL9067973 0.94 CYP3A4 (0.52) LPAR3LPAR2LPAR1CYP3A4AKR1B1
SCHEMBL7648603 0.81 LPAR3 (0.60) LPAR3LPAR2LPAR1PPARGPPARD
SCHEMBL26124288 0.79 NAAA (0.53) LPAR3LPAR2LPAR1CYP3A4ALDH1A1
SCHEMBL31415903 0.79 LPAR3 (0.48) LPAR3LPAR2LPAR1CYP3A4PDE4A
SCHEMBL13932065 0.78 LPAR3 (0.52) LPAR3LPAR2LPAR1CYP3A4ALDH1A1
SCHEMBL2352571 0.78 LPAR3 (0.52) LPAR3LPAR2LPAR1
SCHEMBL2352448 0.78 LPAR3 (0.52) LPAR3LPAR2LPAR1
SCHEMBL2354572 0.78 LPAR3 (0.52) LPAR3LPAR2LPAR1
SCHEMBL2354488 0.78 LPAR3 (0.52) LPAR3LPAR2LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140248317-A1 TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND GLYTECH, INC. (JP) 2014-09-04 US disclosed
EP-2567963-A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound Otsuka Chemical Co., Ltd. (JP) 2013-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140248317-A1 TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND TREH, MAN2B1, NFATC1 LPAR3 3066/4885LPAR2 3059/4885LPAR1 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.